Retatrutide, the newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery

Retatrutide helped participants lose about 30% of their body weight — roughly 70 pounds — in clinical trials. The drug is a “triple-agonist,” designed to target three hormone pathways (GLP-1, GIP and glucagon) to reduce hunger and regulate blood sugar. Photo: Getty Images.

Retatrutide, the newest type of weight-loss drug, helped people lose an average of 70 pounds or about 30% of their body weight over 80 weeks, according to study data from the drug’s manufacturer. The drug is known as a “triple-agonist,” meaning it targets three different receptors in the brain and throughout the body. “We’ve never … Continue reading Retatrutide, the newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery

UCHealth Today